Glanbia plc (LON:GLB – Get Free Report) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 17.50 ($0.22) and traded as high as GBX 18.44 ($0.23). Glanbia shares last traded at GBX 17.65 ($0.22), with a volume of 61 shares changing hands.
Glanbia Stock Performance
The company has a current ratio of 1.68, a quick ratio of 0.86 and a debt-to-equity ratio of 36.19. The firm’s 50-day simple moving average is GBX 17.50 and its two-hundred day simple moving average is GBX 15.99. The company has a market cap of £46.09 million, a PE ratio of 14.71, a P/E/G ratio of 8.32 and a beta of 0.55.
Glanbia Increases Dividend
The business also recently declared a dividend, which was paid on Friday, May 3rd. Stockholders of record on Thursday, March 21st were given a €0.21 ($0.23) dividend. This represents a dividend yield of 1.38%. This is a positive change from Glanbia’s previous dividend of $0.14. The ex-dividend date was Thursday, March 21st. Glanbia’s payout ratio is presently 2,916.67%.
Glanbia Company Profile
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
Featured Articles
- Five stocks we like better than Glanbia
- Compound Interest and Why It Matters When Investing
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is the Dow Jones Industrial Average (DJIA)?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.